Yue Wang1, Ming Cui2, Bao-di Sun2, Fa-bao Liu1, Xiao-dong Zhang2, Li-hong Ye1. 1. State Key Laboratory of Medicinal Chemical Biology, Department of Biochemistry, College of Life Sciences, Nankai University, Tianjin 300071, China. 2. State Key Laboratory of Medicinal Chemical Biology, Department of Cancer Research, College of Life Sciences, Nankai University, Tianjin 300071, China.
Abstract
AIM: MiR-506 is a miRNA involved in carcinogenesis of several kinds of cancer. In this study, we explored whether miR-506 played a critical role in hepatocellular carcinoma (HCC). METHODS: Twenty HCC and adjacent normal liver tissue samples were collected. Human hepatoma cell lines HepG2 and H7402 were used for in vitro studies. The expression of miR-506 and transcriptional co-activator YAP was examined using qRT-PCR. Western blot analysis was used to measure the expression of YAP and its target genes. Luciferase reporter gene assay was used to identify YAP as a target gene of miR-506. MTT and EdU assays were carried out for functional analysis. RESULTS: The expression of miR-506 was significantly lower in HCC than in adjacent normal liver tissues. Bioinformatics analysis revealed that YAP mRNA might be one of the targets of miR-506, and miR-506 in HCC tissues was found to be negatively correlated with YAP (r=-0.605). In both HepG2 and H7402 cells, miR-506 dose-dependently down-regulated YAP and its target genes c-Myc and the connective tissue growth factor (CTGF). Luciferase reporter gene assays demonstrated that miR-506 targeted the wild type 3'UTR of YAP mRNA, but not a 3'UTR with a mutant seed site. Furthermore, miR-506 significantly inhibited the proliferation of HepG2 and H7402 cells, while anti-miR-506 enhanced the cell proliferation, which was blocked by YAP siRNA. CONCLUSION: MiR-506 suppresses the proliferation of hepatoma cells by targeting YAP mRNA.
AIM: MiR-506 is a miRNA involved in carcinogenesis of several kinds of cancer. In this study, we explored whether miR-506 played a critical role in hepatocellular carcinoma (HCC). METHODS: Twenty HCC and adjacent normal liver tissue samples were collected. Humanhepatoma cell lines HepG2 and H7402 were used for in vitro studies. The expression of miR-506 and transcriptional co-activator YAP was examined using qRT-PCR. Western blot analysis was used to measure the expression of YAP and its target genes. Luciferase reporter gene assay was used to identify YAP as a target gene of miR-506. MTT and EdU assays were carried out for functional analysis. RESULTS: The expression of miR-506 was significantly lower in HCC than in adjacent normal liver tissues. Bioinformatics analysis revealed that YAP mRNA might be one of the targets of miR-506, and miR-506 in HCC tissues was found to be negatively correlated with YAP (r=-0.605). In both HepG2 and H7402 cells, miR-506 dose-dependently down-regulated YAP and its target genes c-Myc and the connective tissue growth factor (CTGF). Luciferase reporter gene assays demonstrated that miR-506 targeted the wild type 3'UTR of YAP mRNA, but not a 3'UTR with a mutant seed site. Furthermore, miR-506 significantly inhibited the proliferation of HepG2 and H7402 cells, while anti-miR-506 enhanced the cell proliferation, which was blocked by YAP siRNA. CONCLUSION:MiR-506 suppresses the proliferation of hepatoma cells by targeting YAP mRNA.
Authors: Jin Lu Tong; Chen Peng Zhang; Fang Nie; Xi Tao Xu; Ming Ming Zhu; Shu Dong Xiao; Zhi Hua Ran Journal: FEBS Lett Date: 2011-10-22 Impact factor: 4.124
Authors: Raquel Urtasun; Maria U Latasa; Maria I Demartis; Stella Balzani; Saioa Goñi; Oihane Garcia-Irigoyen; Maria Elizalde; Maria Azcona; Rosa M Pascale; Francesco Feo; Paulette Bioulac-Sage; Charles Balabaud; Jordi Muntané; Jesus Prieto; Carmen Berasain; Matias A Avila Journal: Hepatology Date: 2011-12 Impact factor: 17.425
Authors: Fernando D Camargo; Sumita Gokhale; Jonathan B Johnnidis; Dongdong Fu; George W Bell; Rudolf Jaenisch; Thijn R Brummelkamp Journal: Curr Biol Date: 2007-11-01 Impact factor: 10.834
Authors: Nan Bai; Chunyan Zhang; Ning Liang; Zhuhong Zhang; Antao Chang; Jing Yin; Zongjin Li; Na Luo; Xiaoyue Tan; Na Luo; Yunping Luo; Rong Xiang; Xiru Li; Ralph A Reisfeld; Dwayne Stupack; Dan Lv; Chenghu Liu Journal: Cancer Biol Ther Date: 2013-06 Impact factor: 4.742
Authors: M Yin; X Ren; X Zhang; Y Luo; G Wang; K Huang; S Feng; X Bao; K Huang; X He; P Liang; Z Wang; H Tang; J He; B Zhang Journal: Oncogene Date: 2014-01-27 Impact factor: 9.867
Authors: Wei Dai; Hai-Li Huang; Min Hu; Si-Jie Wang; Hui-Juan He; Nian-Pin Chen; Ming-Yi Li Journal: Am J Cancer Res Date: 2015-08-15 Impact factor: 6.166